Back to search

Article

Cannabidiol and refractory epilepsy: parental and caregiver perspectives of participation in a compassionate access scheme

2021-05-11

Abstract excerpt

<h4>Background: </h4> The Compassionate Access Scheme (CAS) being delivered through the Queensland Children’s Hospital is designed to allow access to an investigational purified Cannabidiol oral solution to paediatric patients with severe refractory epilepsy. The objectives of this study were to conduct semi-structured interviews to: 1. Understand families’ expectations and attitudes about the use of an investigat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fd1cd128-9b99-5780-88ca-d7fe6099f596
DOI
10.21203/rs.3.rs-38814/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cannabidiol and refractory epilepsy: parental and caregiver perspectives of participation in a compassionate access schemeDOI 10.21203/rs.3.rs-38814/v2
Potential clinical benefits of CBD-rich Cannabis extracts over purified CBD in treatment-resistant epilepsy: observational data meta-analysisSemantic proximity
Seizure Control Among Children on Anti-epileptic Drugs at a Tertiary Hospital in South Western Uganda- A Retrospective Cohort StudySemantic proximity
The Global Epilepsy Needs Study (GENS): A mixed-methods, multi-country exploration of the unmet psychosocial and everyday needs of people with epilepsySemantic proximity
Usual care for mental health problems in children with epilepsy: A cohort studySemantic proximity
Tastes and colours: a qualitative study of the lived experience of methylphenidate prescribed for children with a fetal alcohol spectrum disorderSemantic proximity
Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing StudiesSemantic proximity
Colombian consensus of treatment with pure cannabidiol (CBD) in PsychiatrySemantic proximity
A large Australian longitudinal cohort registry demonstrates sustained safety and efficacy of oral medicinal cannabis for at least two yearsSemantic proximity
Utilization and Therapeutic Choices after a First Seizure: A Mixed- Methods Analysis of Determinants in a Malian CohortSemantic proximity
Safety and efficacy of orally administered full-spectrum medicinal cannabis plant extract 0.08% THC (NTI-164) in children with autism spectrum disorder: An open-label studySemantic proximity
Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex.Semantic proximity
The Use of Cannabis Derived Medical Products in the Treatment of Children’s Cancer: A Systematic ReviewSemantic proximity
Select a neighboring publication to make it the new centre.